JP2018523483A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018523483A5 JP2018523483A5 JP2018509494A JP2018509494A JP2018523483A5 JP 2018523483 A5 JP2018523483 A5 JP 2018523483A5 JP 2018509494 A JP2018509494 A JP 2018509494A JP 2018509494 A JP2018509494 A JP 2018509494A JP 2018523483 A5 JP2018523483 A5 JP 2018523483A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- medicament
- fusion polypeptide
- amino acid
- medicament according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15181800 | 2015-08-20 | ||
| EP15181800.2 | 2015-08-20 | ||
| PCT/EP2016/069680 WO2017029389A1 (en) | 2015-08-20 | 2016-08-19 | B7-h1 fusion polypeptides for treating and preventing organ failure |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018523483A JP2018523483A (ja) | 2018-08-23 |
| JP2018523483A5 true JP2018523483A5 (https=) | 2019-09-26 |
| JP6859320B2 JP6859320B2 (ja) | 2021-04-14 |
Family
ID=54014503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018509494A Active JP6859320B2 (ja) | 2015-08-20 | 2016-08-19 | 臓器不全の治療および予防用のｂ７−ｈ１融合ポリペプチド |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10632174B2 (https=) |
| EP (1) | EP3337496B1 (https=) |
| JP (1) | JP6859320B2 (https=) |
| CN (2) | CN114767833A (https=) |
| CA (1) | CA2995987C (https=) |
| ES (1) | ES2851474T3 (https=) |
| WO (1) | WO2017029389A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121159719A (zh) | 2015-04-17 | 2025-12-19 | 高山免疫科学股份有限公司 | 具有可调的亲和力的免疫调节蛋白 |
| WO2017181152A2 (en) | 2016-04-15 | 2017-10-19 | Alpine Immune Sciences, Inc. | Cd80 variant immunomodulatory proteins and uses thereof |
| WO2018022945A1 (en) | 2016-07-28 | 2018-02-01 | Alpine Immune Sciences, Inc. | Cd112 variant immunomodulatory proteins and uses thereof |
| US11471488B2 (en) | 2016-07-28 | 2022-10-18 | Alpine Immune Sciences, Inc. | CD155 variant immunomodulatory proteins and uses thereof |
| SG11201907769XA (en) | 2017-03-16 | 2019-09-27 | Alpine Immune Sciences Inc | Cd80 variant immunomodulatory proteins and uses thereof |
| KR20190141146A (ko) | 2017-03-16 | 2019-12-23 | 알파인 이뮨 사이언시즈, 인코포레이티드 | Pd-l2 변이체 면역조절 단백질 및 그의 용도 |
| EP3596116B1 (en) * | 2017-03-16 | 2023-09-06 | Alpine Immune Sciences, Inc. | Pd-l1 variant immunomodulatory proteins and uses thereof |
| AU2019205273B2 (en) | 2018-01-03 | 2024-04-04 | Alpine Immune Sciences, Inc. | Multi-domain immunomodulatory proteins and methods of use thereof |
| CA3120868A1 (en) | 2018-11-30 | 2020-06-04 | Alpine Immune Sciences, Inc. | Cd86 variant immunomodulatory proteins and uses thereof |
| US10650210B1 (en) | 2019-03-18 | 2020-05-12 | Haier Us Appliance Solutions, Inc. | Method for authenticating a filter cartridge for a refrigerator appliance |
| WO2021219807A1 (en) | 2020-04-30 | 2021-11-04 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Pd-l1 variants with improved affinity towards pd-1 |
| WO2021231376A2 (en) | 2020-05-12 | 2021-11-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| WO2022056014A1 (en) * | 2020-09-09 | 2022-03-17 | Cue Biopharma, Inc. | Mhc class ii t-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (t1d) and methods of use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014121085A1 (en) | 2013-01-31 | 2014-08-07 | Thomas Jefferson University | Pd-l1 and pd-l2-based fusion proteins and uses thereof |
| ES2714708T3 (es) * | 2013-10-01 | 2019-05-29 | Mayo Found Medical Education & Res | Procedimientos para el tratamiento de cáncer en pacientes con niveles elevados de Bim |
-
2016
- 2016-08-19 WO PCT/EP2016/069680 patent/WO2017029389A1/en not_active Ceased
- 2016-08-19 EP EP16757610.7A patent/EP3337496B1/en active Active
- 2016-08-19 CA CA2995987A patent/CA2995987C/en active Active
- 2016-08-19 CN CN202210458693.3A patent/CN114767833A/zh active Pending
- 2016-08-19 JP JP2018509494A patent/JP6859320B2/ja active Active
- 2016-08-19 ES ES16757610T patent/ES2851474T3/es active Active
- 2016-08-19 CN CN201680044831.6A patent/CN107921093B/zh active Active
- 2016-08-19 US US15/753,541 patent/US10632174B2/en active Active
-
2020
- 2020-03-18 US US16/822,240 patent/US11679142B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018523483A5 (https=) | ||
| Foster | Surface proteins of Staphylococcus aureus | |
| Santos-Zas et al. | Adaptive immune responses contribute to post-ischemic cardiac remodeling | |
| JP2018029594A5 (https=) | ||
| JP2017515460A5 (https=) | ||
| JP2018512856A5 (https=) | ||
| EP4282430A3 (en) | Garp-tgf-beta antibodies | |
| JP2014530253A5 (https=) | ||
| Kroger et al. | Therapies to suppress β cell autoimmunity in type 1 diabetes | |
| JP2014508748A5 (https=) | ||
| JP2017538401A5 (https=) | ||
| JP2020501550A5 (https=) | ||
| US20160199479A1 (en) | T cell receptors | |
| JP2019519215A5 (https=) | ||
| JP2013506411A5 (https=) | ||
| HK1210792A1 (en) | Molecules with antigen binding and polyvalent fc gamma receptor binding activity | |
| JP2018509936A5 (https=) | ||
| JP2020507561A5 (https=) | ||
| JP2018509163A5 (https=) | ||
| JP2018520679A5 (https=) | ||
| JP2018508219A5 (https=) | ||
| JP2016527314A5 (https=) | ||
| JP2019510739A5 (https=) | ||
| JP2015509707A5 (https=) | ||
| JP7313017B2 (ja) | ＭＨＣクラスＩａオープンコンフォーマー |